Video
22 Jan 2024
Tablet and Capsule manufacturing plant.
JPG 519 kB
Content provided by our supplier
Crassula Pharmaceuticals
-
US
-
2023On CPHI since
-
2Certificates
-
500 - 999Employees
Company types
Primary activities
Other Content from Crassula Pharmaceuticals (1)
-
News Crassula Pharmaceuticals Launches Estarol, Atorvastatin 20mg and 40mg Coated Tablets, in Honduras
Tegucigalpa, Honduras – Crassula Honduras, a leader in pharmaceutical manufacturing, announces the launch of Estarol, atorvastatin in 20mg and 40mg coated tablets, reinforcing its commitment to advancing cardiovascular health in Honduras. Estarol is formulated to lower high cholesterol and reduce the risk of heart disease, showcasing Crassula Honduras’s dedication to offering comprehensive healthcare solutions.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance